Roswell Park Cancer Institute
NCI Grants $1.9M to Roswell Park to Study Molecular Race-Based Breast Cancer Disparities
The grant will fund an investigation into long noncoding RNA and the role it plays in differing prognoses between Black and white breast cancer patients.
Roswell Park, Catholic Health, University of Buffalo Partner on Coronavirus Sequencing Study
The study, which is being supported by Thermo Fisher Scientific, aims to identify genetic biomarkers that can predict patients likely to develop severe disease.
Ovarian Cancer Omics Consortium Receives $500K DoD Grant for Early Detection Biomarker Discovery
The consortium is comprised of researchers from Inova, Roswell Park Comprehensive Cancer Center, the Mayo Clinic, and MD Anderson Cancer Center.
Kiyatec's cell-based assays model and predict patient therapeutic response to drive cancer drug development and potentially guide treatment.
OmniSeq, LabCorp Extend Distribution Deal
LabCorp will further invest in OmniSeq as part of the deal, which covers distribution of the latter's immune profiling and pan-cancer next-generation sequencing tests.